Decision letter for "Sex-Specific Changes in GLP-1RA Trends (2019-2024): Impact of FDA Approval of Semaglutide (Wegovy) for Chronic Weight Management in United States"

Publons reviews and discussion 2026

View at publisher

DOI: 10.1111/dom.70555/v3/decision1

Cited by: 0

Fields of Study & Subjects

Diabetes Treatment and Management Pharmacology and Obesity Treatment Pharmaceutical Economics and Policy